Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 371

2.
3.

LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis.

Zhou X, Caligiuri G, Hamsten A, Lefvert AK, Hansson GK.

Arterioscler Thromb Vasc Biol. 2001 Jan;21(1):108-14.

4.
5.

Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis.

Palinski W, Tangirala RK, Miller E, Young SG, Witztum JL.

Arterioscler Thromb Vasc Biol. 1995 Oct;15(10):1569-76.

7.
8.
9.

Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.

Gounopoulos P, Merki E, Hansen LF, Choi SH, Tsimikas S.

Minerva Cardioangiol. 2007 Dec;55(6):821-37. Review.

PMID:
18091649
10.

Immunization of low-density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis.

Afek A, George J, Gilburd B, Rauova L, Goldberg I, Kopolovic J, Harats D, Shoenfeld Y.

J Autoimmun. 2000 Mar;14(2):115-21.

PMID:
10677242
11.

The pro-inflammatory effect of uraemia overrules the anti-atherogenic potential of immunization with oxidized LDL in apoE-/- mice.

Pedersen TX, Binder CJ, Fredrikson GN, Nilsson J, Bro S, Nielsen LB.

Nephrol Dial Transplant. 2010 Aug;25(8):2486-91. doi: 10.1093/ndt/gfq059. Epub 2010 Feb 17.

PMID:
20164045
12.

Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis.

Turunen SP, Kummu O, Wang C, Harila K, Mattila R, Sahlman M, Pussinen PJ, Hörkkö S.

Innate Immun. 2015 May;21(4):370-85. doi: 10.1177/1753425914542444. Epub 2014 Aug 17.

PMID:
25134521
13.

Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo.

Shaw PX, Hörkkö S, Tsimikas S, Chang MK, Palinski W, Silverman GJ, Chen PP, Witztum JL.

Arterioscler Thromb Vasc Biol. 2001 Aug;21(8):1333-9.

14.

Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon injury in hypercholesterolemic rabbits.

Nilsson J, Calara F, Regnstrom J, Hultgardh-Nilsson A, Ameli S, Cercek B, Shah PK.

J Am Coll Cardiol. 1997 Dec;30(7):1886-91.

15.

Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits.

Ameli S, Hultgårdh-Nilsson A, Regnström J, Calara F, Yano J, Cercek B, Shah PK, Nilsson J.

Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):1074-9.

16.

Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I.

George J, Afek A, Gilburd B, Blank M, Levy Y, Aron-Maor A, Levkovitz H, Shaish A, Goldberg I, Kopolovic J, Harats D, Shoenfeld Y.

Circulation. 1998 Sep 15;98(11):1108-15.

17.

Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice.

Habets KL, van Puijvelde GH, van Duivenvoorde LM, van Wanrooij EJ, de Vos P, Tervaert JW, van Berkel TJ, Toes RE, Kuiper J.

Cardiovasc Res. 2010 Feb 1;85(3):622-30. doi: 10.1093/cvr/cvp338. Epub 2009 Oct 9.

PMID:
19819882
18.

Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis.

George J, Afek A, Gilburd B, Levkovitz H, Shaish A, Goldberg I, Kopolovic Y, Wick G, Shoenfeld Y, Harats D.

Atherosclerosis. 1998 May;138(1):147-52.

PMID:
9678780
19.

Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis.

Schiopu A, Bengtsson J, Söderberg I, Janciauskiene S, Lindgren S, Ares MP, Shah PK, Carlsson R, Nilsson J, Fredrikson GN.

Circulation. 2004 Oct 5;110(14):2047-52. Epub 2004 Sep 27.

20.

Supplemental Content

Support Center